J. Flood

发表

Assessing Complexity Among Patients With Tuberculosis in California, 1993–2016

P. Barry, A. Vaisman, J. Flood, 2020, Open forum infectious diseases.

Reexamining the Prevalence of Chlamydia trachomatis Infection Among Gay Men With Urethritis: Implications for STD Policy and HIV Prevention Activities

C. Kent, J. Klausner, E. Ciemins, 2000, Sexually transmitted diseases.

Extensively drug-resistant tuberculosis: new strains, new challenges

T. Porco, G. Schecter, J. Flood, 2008, Expert review of anti-infective therapy.

Opportunities for Tuberculosis Diagnosis and Prevention among Persons Living with HIV: A Cross-Sectional Study of Policies and Practices at Four Large Ryan White Program-Funded HIV Clinics

J. Franks, P. Colson, Y. Hirsch-Moverman, 2014, PloS one.

Improved Outcomes Found after Implementing a Systematic Evaluation and Program Improvement Process for Tuberculosis

S. Royce, T. Shaw, J. Flood, 2013, Public health reports.

Linezolid in the treatment of multidrug-resistant tuberculosis.

G. Schecter, S. Mase, J. Flood, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Tuberculosis Elimination Efforts in the United States in the Era of Insurance Expansion and the Affordable Care Act

V. Balaban, T. Chorba, J. Higashi, 2015, Public health reports.

Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis.

Sonya S. Shin, T. Holtz, J. Yim, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Outcomes of Pediatric Central Nervous System Tuberculosis in California, 1993-2011.

P. Barry, J. Flood, Alexandra Duque-Silva, 2018, Journal of the Pediatric Infectious Diseases Society.

The California Multidrug-Resistant Tuberculosis Consult Service: a partnership of state and local programs.

P. Barry, G. Schecter, J. Westenhouse, 2018, Public health action.

Treatment Practices, Outcomes, and Costs of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis, United States, 2005–2007

Lori Armstrong, Edward A. Graviss, L. Armitige, 2014, Emerging infectious diseases.

Outcomes and costs of out-patient MDR-TB care in the USA.

L. Armitige, E. Graviss, L. Armstrong, 2017, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

A systematic synthesis of direct costs to treat and manage tuberculosis disease applied to California, 2015

P. Barry, L. Pascopella, J. Flood, 2017, BMC Research Notes.

Characteristics and costs of multidrug-resistant tuberculosis in-patient care in the United States, 2005-2007.

L. Armitige, E. Graviss, L. Armstrong, 2016, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Rapid Drug Susceptibility Testing with a Molecular Beacon Assay Is Associated with Earlier Diagnosis and Treatment of Multidrug-Resistant Tuberculosis in California

G. Schecter, J. Watt, E. Desmond, 2010, Journal of Clinical Microbiology.

Extensively drug-resistant tuberculosis in california, 1993-2006.

S. Royce, E. Desmond, J. Westenhouse, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cost Resulting from Anti-Tuberculosis Drug Shortages in the United States: A Hypothetical Cohort Study

T. Porco, James C. Scott, J. Flood, 2015, PloS one.

Transmission of multidrug-resistant tuberculosis in the USA: a cross-sectional study.

E. Graviss, P. Moonan, L. Teeter, 2013, The Lancet. Infectious diseases.

Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients

Marcos Burgos, Andrea Benedetti, Madhukar Pai, 2012, PLoS medicine.

Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis

P. Barry, M. Becerra, E. Yablokova, 2019, Emerging infectious diseases.

Laboratory Reporting of Tuberculosis Test Results and Patient Treatment Initiation in California

D. Chin, A. Reingold, S. Royce, 2004, Journal of Clinical Microbiology.

Mycobacterium africanum cases, California.

E. Desmond, W. Probert, Ameena T. Ahmed, 2004, Emerging infectious diseases.

Epidemiology of Tuberculosis Cases with End-Stage Renal Disease, California, 2010

P. Barry, G. Schecter, A. Chitnis, 2014, American Journal of Nephrology.

HIV status determination among tuberculosis patients from California during 2008.

J. Watt, Darryl G Kong, J. Flood, 2013, Journal of public health management and practice : JPHMP.

Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination

J. Salomon, A. Hill, D. Dowdy, 2020, Public health reports.

Tuberculosis and HIV Co-infection, California, USA, 1993–2008

P. Hopewell, Q. Xia, T. Porco, 2012, Emerging infectious diseases.

Transmission of Mycobacterium Tuberculosis Via Lung Transplantation

D. Pegues, K. Winthrop, D. Bruckner, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Determinants of Multidrug-Resistant Tuberculosis Clusters, California, USA, 2004–2007

P. Hopewell, A. Cattamanchi, M. Kato-Maeda, 2010, Emerging infectious diseases.

Mycobacterium africanumCases, California

E. Desmond, W. Probert, Ameena T. Ahmed, 2004 .

Human Exposure following Mycobacterium tuberculosis Infection of Multiple Animal Species in a Metropolitan Zoo

R. Granich, Cynthia E. Stringfield, A. Nitta, 2002, Emerging infectious diseases.

Epidemiology of Human Mycobacterium bovis Disease, California, USA, 2003–2011

Mark Gallivan, J. Flood, N. Shah, 2015, Emerging infectious diseases.

Hantavirus infection following wilderness camping in Washington State and northeastern California.

W. Drew, J. Flood, L. Mintz, 1995, The Western journal of medicine.

Navigating toward TB elimination: the California perspective.

P. Barry, A. Readhead, J. Flood, 2019 .

High Discordance Between Pre-US and Post-US Entry Tuberculosis Test Results Among Immigrant Children: Is it Time to Adopt Interferon Gamma Release Assay for Preentry Tuberculosis Screening?

P. Barry, J. Flood, P. Lowenthal, 2016, The Pediatric infectious disease journal.

Persistent latent tuberculosis reactivation risk in United States immigrants.

R. Reves, N. Walter, J. Painter, 2014, American journal of respiratory and critical care medicine.

Reduced importation of tuberculosis after the implementation of an enhanced pre-immigration screening protocol.

J. Westenhouse, D. Posey, M. Moore, 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Impact and Effectiveness of State-level Tuberculosis interventions in California, Florida, New York and Texas: A model-based analysis.

P. Barry, A. Hill, D. Dowdy, 2019, American journal of epidemiology.

Practice of Epidemiology Impact and Effectiveness of State-Level Tuberculosis Interventions in California, Florida, New York, and Texas: A Model-Based Analysis

P. Barry, A. Hill, M. Oxtoby, 2019 .

Comparative Modelling of Tuberculosis Epidemiology and Policy Outcomes in California.

J. Salomon, P. Barry, A. Hill, 2020, American journal of respiratory and critical care medicine.

Modeling the Impact of Recommendations for Primary Care–Based Screening for Latent Tuberculosis Infection in California

A. J. Goodell, P. Barry, J. Kahn, 2020, Public health reports.

Evaluation of tuberculosis contact investigations in California.

S. Royce, L. Pascopella, T. Shaw, 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Sociodemographic Characteristics, Comorbidities, and Mortality Among Persons Diagnosed With Tuberculosis and COVID-19 in Close Succession in California, 2020

Seemalata Jain, P. Barry, J. Higashi, 2021, JAMA network open.

Community-wide transmission of a strain of Mycobacterium tuberculosis that causes reduced lung pathology in mice.

L. Riley, L. Pascopella, C. M. Crane, 2008, Journal of medical microbiology.

When Tuberculosis Comes Back: Who Develops Recurrent Tuberculosis in California?

K. Deriemer, J. Watt, L. Pascopella, 2011, PloS one.

Mounting Evidence for IFN-γ Release Assay Use in Young Children.

J. Flood, K. Wendorf, 2018, American journal of respiratory and critical care medicine.

Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis.

P. Hopewell, E. Graviss, P. Nahid, 2017, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Risk Factors for Central Nervous System Tuberculosis

P. Barry, J. Flood, Alexandra Duque-Silva, 2015, Pediatrics.

Association of Area-Based Socioeconomic Measures with Tuberculosis Incidence in California

P. Barry, A. Readhead, J. Flood, 2022, Journal of Immigrant and Minority Health.

Impact of a Shortage of First-Line Antituberculosis Medication on Tuberculosis Control — United States, 2012–2013

T. Chorba, S. Mase, J. Flood, 2013, MMWR. Morbidity and mortality weekly report.

The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma–associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission

E. Operskalski, D. Ganem, M. Busch, 1996, Nature Medicine.

Optimal testing choice and diagnostic strategies for latent tuberculosis infection among U.S.-born people living with HIV.

S. Dorman, R. Garfein, T. Sterling, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

T. Holtz, J. Yim, T. Shim, 2018, The Lancet.

Adenovirus type 3 viremia in an adult with toxic shock-like syndrome.

R. M. Hendry, D. Passaro, A. Reingold, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Unexplained deaths due to possibly infectious causes in the United States: defining the problem and designing surveillance and laboratory approaches. The Unexplained Deaths Working Group.

R. Holman, D. Fleming, J. Hadler, 1996, Emerging infectious diseases.

Surveillance for Unexplained Deaths and Critical Illnesses

R. M. Hendry, C. Woods, J. Hadler, 2002, Emerging infectious diseases.

Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis

S. M. Kadri, S. Madhi, J. Yim, 2018, PLoS medicine.

Interruptions in Supplies of Second-Line Antituberculosis Drugs — United States, 2005–2012

T. Chorba, J. Jereb, B. Seaworth, 2013, MMWR. Morbidity and mortality weekly report.

Diagnostic Challenges of Central Nervous System Tuberculosis

C. Glaser, L. Christie, R. Baxter, 2008, Emerging infectious diseases.

Neurosyphilis during the AIDS epidemic, San Francisco, 1985-1992.

G. Bolan, H. Weinstock, J. Flood, 1998, The Journal of infectious diseases.

Population-based Surveillance for Unexplained Death and Critical Illness Possibly Due to Infectious Causes Population-based Surveillance for Unex Was Initiated on All These Sites Were Participants in the Eip, and the Total Population Targeted For

R. M. Hendry, C. Woods, J. Hadler, 2022 .

M. Segal, P. Barry, J. Balmes, 2017, Environmental health perspectives.

Residential urban tree canopy is associated with decreased mortality during tuberculosis treatment in California.

P. Barry, J. Balmes, P. Nahid, 2020, The Science of the total environment.

Increased tuberculosis risk among immigrants arriving in California with abnormal domestic chest radiographs.

P. Barry, J. Watt, J. Flood, 2018, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

University of Groningen Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes

Wiel, Sonya S. Shin, T. Holtz, 2012 .

Diagnosis of cytomegalovirus (CMV) polyradiculopathy and documentation of in vivo anti-CMV activity in cerebrospinal fluid by using branched DNA signal amplification and antigen assays.

S. Follansbee, J. Kolberg, D. Jekic-Mcmullen, 1997, The Journal of infectious diseases.

Outlook for tuberculosis elimination in California: An individual-based stochastic model

A. J. Goodell, P. Barry, A. Hill, 2019, PloS one.

Review of Nucleic Acid Amplification Tests and Clinical Prediction Rules for Diagnosis of Tuberculosis in Acute Care Facilities

P. Barry, G. Schecter, A. Chitnis, 2015, Infection Control & Hospital Epidemiology.

Multidrug resistance among persons with tuberculosis in California, 1994-2003.

Bryan Lewis, T. Porco, R. Granich, 2005, JAMA.

Matching AIDS and tuberculosis registry data to identify AIDS/tuberculosis comorbidity cases in California

Qiang Xia, Janice L Westenhouse, Alan F Schultz, 2011, Health Informatics J..

Multistrain outbreak of chancroid in San Francisco, 1989-1991.

S. Morse, C. Lammel, G. Bolan, 1993, The Journal of infectious diseases.

Identifying the Sources of Tuberculosis in Young Children: A Multistate Investigation

D. Bennett, B. Ellis, Sumi J. Sun, 2002, Emerging infectious diseases.

An ecological study of tuberculosis transmission in California.

L. Riley, J. Westenhouse, J. Flood, 2006, American journal of public health.

Getting to Zero: Tuberculosis Elimination in California

P. Barry, J. Watt, J. Flood, 2016, Current Epidemiology Reports.

Tuberculosis Mortality in the United States: Epidemiology and Prevention Opportunities

P. Barry, S. Buskin, R. Belknap, 2018, Annals of the American Thoracic Society.

Tuberculosis Treatment Managed by Providers outside the Public Health Department: Lessons for the Affordable Care Act

P. Barry, J. Flood, M. Ehman, 2014, PloS one.

Rifampin monoresistant tuberculosis and HIV comorbidity in California, 1993–2008: a retrospective cohort study

P. Barry, P. Hopewell, T. Porco, 2013, AIDS.

Antituberculosis drug resistance acquired during treatment: an analysis of cases reported in California, 1994-2006.

T. Porco, J. Flood, P. Oh, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants

Bryan Lewis, J. Grinsdale, T. Porco, 2006, BMC public health.

Can Primary Care Drive Tuberculosis Elimination? Increasing Latent Tuberculosis Infection Testing and Treatment Initiation at a Community Health Center with a Large Non-U.S.-born Population

J. Flood, Tessa Mochizuki, S. Katrak, 2023, Journal of Immigrant and Minority Health.

State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity

A. Mirzazadeh, P. Barry, A. Hill, 2021, PloS one.

Correction: Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients

T. Holtz, J. Yim, T. Shim, 2012, PLoS Medicine.

Solid organ transplant recipients with tuberculosis disease in California, 2010 to 2020.

P. Barry, M. Fung, A. Readhead, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Evaluation of Chlamydia and Gonorrhea Screening Criteria: San Francisco Sexually Transmitted Disease Clinic: 1997 to 1998

C. Kent, J. Klausner, Elizabeth L Ciemins, 2000, Sexually transmitted diseases.

Re: "Prebiologic Therapy Tuberculosis Screening Experience in a Pediatric Rheumatology Center: TST and IGRA Are Both Necessary".

P. Barry, J. Flood, P. Lowenthal, 2017, The Pediatric Infectious Disease Journal.

Transnational Record Linkage for Tuberculosis Surveillance and Program Evaluation

R. Reves, Kaylynn Aiona, N. Walter, 2015, Public health reports.

Screening for Latent Tuberculosis Infection Among Non-US-Born Adults in the US: A Path Toward Elimination.

P. Shete, J. Flood, Amy S. Tang, 2023, JAMA.

Health insurance, healthcare utilization and language use among populations who experience risk for tuberculosis, California 2014–2017

P. Barry, A. Readhead, J. Flood, 2022, PLoS ONE.

Hospitalizations with TB, California, 2009-2017.

P. Barry, A. Readhead, J. Flood, 2021, The International Journal of Tuberculosis and Lung Disease.